David A. Siegel Biofrontera Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
Shares
3 transactions
About Biofrontera Inc.
- Ticker BFRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 23,551,000
- Market Cap $27.1M
- Description
- Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...